Douglas R. Lowy

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.448Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf214

Top 42%

0.448DataRank

Top 42%7 citations

Subhashini Jagu, Malcolm A. Smith, John Shern, Douglas S. Hawkins, Elaine R. Mardis +26 more

Papers

Driven by 30 papers — median percentile 58. Top paper: “Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial”.

Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30524-6

N/A

4.1DataRank · unranked

133 citations

Sabrina H. Tsang, Rolando Herrero, Diego Guillén, Teresa M. Darragh, Mark H. Stoler +26 more

Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial

The Lancet Oncology(2022)10.1016/s1470-2045(22)00291-1

N/A

1.9DataRank · unranked

53 citations

Shangying Hu, Rolando Herrero, Allan Hildesheim, Carolina Porras, Joshua N. Sampson +23 more

molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history

Nature Communications(2022)10.1038/s41467-021-27628-3

N/A

1.8DataRank · unranked

64 citations

Nicolas F. Schlecht, Sarah Pickering, LaShanda Williams, Christopher C. Sollecito, Ana Gradíssimo +30 more

Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial

Vaccine(2021)10.1016/j.vaccine.2021.11.041

N/A

1.3DataRank · unranked

42 citations

Joshua N. Sampson, Rolando Herrero, Mitchell H. Gail, Bernal Cortés, Allan Hildesheim +26 more

The Effect of Advances in Lung-Cancer Treatment on Population Mortality

New England Journal of Medicine(2020)10.1056/nejmoa1916623

N/A

1.1DataRank · unranked

1769 citations

Gonçalo Forjaz, Meghan J. Mooradian, Rafael Meza, Chung Yin Kong, Kathleen A. Cronin +4 more

HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer

mBio(2024)10.1128/mbio.00729-24

N/A

0.974DataRank · unranked

39 citations

Vladimır Majerčiak, Alexei Lobanov, Sameer Mirza, Vimla Band, Haibin Liu +5 more

HPV16/18 antibodies 16-years after single dose of bivalent HPV vaccination: Costa Rica HPV vaccine trial

JNCI Monographs(2024)10.1093/jncimonographs/lgae032

N/A

0.933DataRank · unranked

31 citations

Byron Romero, Troy J. Kemp, Romain Fantin, Rolando Herrero, Allan Hildesheim +26 more

The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment

Cell(2021)10.1016/j.cell.2021.02.055

N/A

0.790DataRank · unranked

193 citations

Jean C. Zenklusen, Louis M. Staudt, James H. Doroshow, Douglas R. Lowy, Henry Rodriguez

An Introduction to Virus Infections and Human Cancer

Recent results in cancer research/Recent Results in Cancer Research(2020)10.1007/978-3-030-57362-1_1

N/A

0.738DataRank · unranked

136 citations

Douglas R. Lowy, John T. Schiller

Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020

Clinical Infectious Diseases(2021)10.1093/cid/ciab519

N/A

0.520DataRank · unranked

31 citations

David J. Schlueter, Hoda Anton‐Culver, James D. Cherry, Joshua C. Denny, Isaac Thomsen +17 more

Strategies to decrease inequalities in cancer therapeutics, care and prevention

Molecular Oncology(2023)10.1002/1878-0261.13575

N/A

0.477DataRank · unranked

23 citations

Joachim von Braun, Julio E. Celis, Michaël Baumann, Anton Berns, Alexander M.M. Eggermont +32 more

Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf214

Top 42%

0.448DataRank

Top 42%7 citations

Subhashini Jagu, Malcolm A. Smith, John Shern, Douglas S. Hawkins, Elaine R. Mardis +26 more

Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad064

N/A

0.355DataRank · unranked

5 citations

Nicole G. Campos, Didem Egemen, Rolando Herrero, Mark Schiffman, Carolina Porras +26 more

Human papillomavirus type 16 and 18 viral clearance and progression to precancer among women aged 18–25 years enrolled in the Costa Rica HPV prophylactic vaccine trial (CVT)

Vaccine(2025)10.1016/j.vaccine.2025.126841

N/A

0.208DataRank · unranked

3 citations

Loretto J Carvajal, Peter Dull, Rolando Herrero, John Schussler, Allan Hildesheim +8 more

The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling in human papillomavirus type 16-infected cervical cancer cells

eLife(2024)10.7554/elife.102681

N/A

0.172DataRank · unranked

2 citations

Lulu Yu, Vladimır Majerčiak, Thomas J. Meyer, Ming Yi, Peter F. Johnson +4 more

Post-attachment neutralization of HPV16 by antibodies derived from Gardasil-vaccinated women

npj Vaccines(2025)10.1038/s41541-025-01286-8

N/A

0.165DataRank · unranked

2 citations

Cynthia D. Thompson, Erin M. Scherer, J J Carter, Denise A. Galloway, Douglas R. Lowy +2 more

The lnc-FANCI-2 intrinsically restricts RAS signaling in HPV16-infected cervical cancer

eLife(2025)10.7554/elife.102681.2

N/A

0DataRank · unranked

0 citations

Lulu Yu, Vladimır Majerčiak, Thomas Meyer, Ming Yi, Peter F. Johnson +4 more

Risk Factors for Non–Human Papillomavirus (HPV) Type 16/18 Cervical Infections and Associated Lesions Among HPV DNA–Negative Women Vaccinated Against HPV-16/18 in the Costa Rica Vaccine Trial

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa768

N/A

0DataRank · unranked

10 citations

Sabrina H. Tsang, Shangying Hu, Carolina Porras, Rolando Herrero, Aimée R. Kreimer +26 more

Cancer-Associated Point Mutations in the DLC1 Tumor Suppressor and Other Rho-GAPs Occur Frequently and Are Associated with Decreased Function

Cancer Research(2020)10.1158/0008-5472.can-19-3984

N/A

0DataRank · unranked

24 citations

Xiaolan Qian, Beatriz Sánchez‐Solana, Brajendra K. Tripathi, Marian E. Durkin, Douglas R. Lowy +1 more

The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1

Molecular Cancer(2021)10.1186/s12943-021-01439-y

N/A

0DataRank · unranked

27 citations

Dunrui Wang, Xiaolan Qian, Velayoudame Parthibane, Dhirendra K. Simanshu, Jairaj Acharya +2 more

Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein

Nature Communications(2021)10.1038/s41467-021-26993-3

N/A

0DataRank · unranked

23 citations

Meghan F. Anderman, Disha Bhargava, Luciarita Boccuzzi, Xiaolan Qian, Dunrui Wang +8 more

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial

npj Vaccines(2022)10.1038/s41541-022-00431-x

N/A

0DataRank · unranked

10 citations

John T. Schiller, Carolina Porras, Troy J. Kemp, Rolando Herrero, John Schussler +26 more

Prospects for preventing cancer with anti-microbial prophylactic vaccines

Cell Host & Microbe(2022)10.1016/j.chom.2022.10.016

N/A

0DataRank · unranked

5 citations

Douglas R. Lowy, John T. Schiller

Duration of Protection Against SARS-CoV-2 Reinfection and Associated Risk of Reinfection Assessed with Real-World Data

medRxiv(2022)10.1101/2022.02.25.22271515

N/A

0DataRank · unranked

4 citations

Harvey W. Kaufman, William A. Meyer, Chris Bush, Oren J. Cohen, Kathy A. Cronin +8 more

A cancer-associated K-RAS mutant that preferentially binds GDP displays gain-of-function and atypical signaling

Research Square(2022)10.21203/rs.3.rs-1521657/v1

N/A

0DataRank · unranked

1 citations

Tatu Pantsar, Alex G. Papageorge1, Brajendra K. Tripathi, Beatriz Sánchez‐Solana, Marian E. Durkin +8 more

SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines

Human Vaccines & Immunotherapeutics(2023)10.1080/21645515.2023.2215677

N/A

0DataRank · unranked

18 citations

Troy J. Kemp, Jimmie L. Bullock, Aaron J. Bouk, Jordan B. Metz, Abigail Neish +4 more

Assay Harmonization Study To Measure Immune Response to SARS-CoV-2 Infection and Vaccines: a Serology Methods Study

Microbiology Spectrum(2023)10.1128/spectrum.05353-22

N/A

0DataRank · unranked

14 citations

Heidi Hempel, Yuanji Pan, Daisy Roy, James D. Cherry, Douglas R. Lowy +2 more

Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial

npj Vaccines(2024)10.1038/s41541-024-00896-y

N/A

0DataRank · unranked

9 citations

Carolina Porras, Maísa Pinheiro, Rolando Herrero, Allan Hildesheim, Danping Liu +37 more

A cervical cancer control strategy for lower-resource settings: interventions to complement one-dose HPV vaccination

JNCI Monographs(2024)10.1093/jncimonographs/lgae040

N/A

0DataRank · unranked

4 citations

Douglas R. Lowy, Silvia de Sanjosé, Mark Schiffman, Nicole G. Campos

The lnc-FANCI-2 intrinsically restricts RAS signaling in HPV16-infected cervical cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.01.578320

N/A

0DataRank · unranked

0 citations

Lulu Yu, Vladimır Majerčiak, Thomas Meyer, Ming Yi, Peter F. Johnson +4 more

Douglas R. Lowy

Indexed papers

Top data-sharing exemplar

Papers